NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
OTTAWA, March 17, 2021 – Calian Group Ltd. (“Calian” or the “Company”) (TSX:CGY) is pleased to announce that it has completed its previously announced bought deal offering, under which a total of 1,318,000 common shares of the Company (the “Common Shares“) were sold at a price of $60.50 per Common Share for aggregate gross proceeds of $79,739,000, including 78,000 Common Shares issued pursuant to the partial exercise of the over-allotment option granted to the Underwriters (as defined below) (the “Offering“). The Offering was conducted by a syndicate of underwriters co-led by Desjardins Capital Markets and Acumen Capital Finance Partners Limited, and including Canaccord Genuity Corp., CIBC Capital Markets, Stifel GMP, Echelon Capital Markets, Laurentian Bank Securities and Cormark Securities Inc. (collectively, the “Underwriters”).
The Company intends to use the net proceeds from the Offering to, among other things and as more fully described in the Prospectus Supplement (as defined below), pursue strategic growth initiatives and for general corporate and working capital purposes.
The Common Shares were offered (i) by way of a prospectus supplement dated March 10, 2021 (the “Prospectus Supplement”) to the Company’s amended and restated final short form base shelf prospectus dated February 25, 2021 (amending and restating its final short form base shelf prospectus dated January 31, 2020), which Prospectus Supplement was filed with the securities commissions and other similar regulatory authorities in each of the provinces of Canada; and (ii) in jurisdictions outside of Canada and the United States as agreed to by the Company and the Underwriters on a private placement or equivalent basis.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and applicable U.S. state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements thereunder.
About Calian
We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex problems. That’s Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit calian.com to learn about innovative healthcare, communications, learning and cybersecurity solutions.
Product or service names mentioned herein may be the trademarks of their respective owners.
Media inquiries:[email protected] 613-599-8600 x 2298 Investor Relations inquiries:[email protected]
DISCLAIMER
Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.
Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
Tel: 613.599.8600 · Fax: 613-592-3664 · General info email: [email protected]